ENDURE

DEAD

Serial Number

87436381

Owner

SUN PHARMACEUTICAL INDUSTRIES LIMITED

Attorney

Craig Kuchii

Filing Date

May 4, 2017

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ENDURE Trademark

Serial Number: 87436381 • Registration: 5760230

ENDURE is a trademark filed by SUN PHARMACEUTICAL INDUSTRIES LIMITED on May 4, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 10 - Medical Apparatus

Surgical, medical, dental and veterinary apparatus and instruments

Owner Contact Info

SUN PHARMACEUTICAL INDUSTRIES LIMITED (295 trademarks)

VADODARA, GUJARAT 390012 , IN

Entity Type: 16

SUN PHARMA GLOBAL FZE (90 trademarks)

EXECUTIVE SUITE Y-43
SHARJAH , AE

Entity Type: 16

Legal Representation

Attorney of Record

Craig Kuchii

241 trademarks filed View all →

Correspondence Address

Craig Kuchii Sun Pharma

2 Independence Way

Intellectual Property Dept.

Princeton, NJ 08540

UNITED STATES

Trademark Details

Filing Date

May 4, 2017

Registration Date

May 28, 2019

Published for Opposition

August 7, 2018

Cancellation Date

December 12, 2025

Goods & Services

(Based on 44(e)) Needle-based and needle-free injection systems; Needles for injections; Syringes for medical purposes and for injections; Drug delivery systems; Injection syringes; Injection instruments with needles; Medical device for accessing subcutaneous structures of the human body for the purpose of administering medical treatment; Medical needles and introducers; Medical syringes; Medical fluid injectors

(Based on 44(e)) Medicated dermatological preparations and substances; Parapharmaceutical products for use in dermatology; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology

Filing History

CANCELLED SEC. 8 (6-YR)

Dec 12, 2025 C8..

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

May 28, 2024 REM1

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Sep 7, 2022 ASGN

REGISTERED-PRINCIPAL REGISTER

May 28, 2019 R.PR

1(B) BASIS DELETED; PROCEED TO REGISTRATION

Apr 19, 2019 DP1B

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 19, 2019 AITU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 29, 2019 EXRA

NOTICE OF ALLOWANCE CANCELLED

Mar 27, 2019 IUCN

SOU EXTENSION 1 GRANTED

Mar 27, 2019 EX1G

SOU EXTENSION 1 FILED

Mar 27, 2019 EXT1

SOU TEAS EXTENSION RECEIVED

Mar 27, 2019 EEXT

TEAS DELETE 1(B) BASIS RECEIVED

Mar 27, 2019 D1BR

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 2, 2018 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 7, 2018 NPUB

PUBLISHED FOR OPPOSITION

Aug 7, 2018 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 18, 2018 NONP

LAW OFFICE PUBLICATION REVIEW COMPLETED

Jul 3, 2018 PREV

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 2, 2018 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 28, 2018 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 28, 2018 CRFA

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Jun 26, 2018 ERSI

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

Dec 29, 2017 GNS2

INQUIRY TO SUSPENSION E-MAILED

Dec 29, 2017 GNSI

SUSPENSION INQUIRY WRITTEN

Dec 29, 2017 CNSI

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

Dec 6, 2017 RCCK

ASSIGNED TO LIE

Dec 3, 2017 ALIE

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Jun 1, 2017 GNS3

LETTER OF SUSPENSION E-MAILED

Jun 1, 2017 GNSL

SUSPENSION LETTER WRITTEN

Jun 1, 2017 CNSL

ASSIGNED TO EXAMINER

May 30, 2017 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 9, 2017 NWOS

NEW APPLICATION ENTERED

May 8, 2017 NWAP

Related Trademarks

More from this Owner

More in Same Class

GENOVÉ DERMATOLOGICS PILOPEPTAN

CAVIWIPES

PREDNISOLONE SODIUM PHOSPHATE AND KETOROLAC TROMETHAMINE 1% / 0.5% OMNI BY OCULAR SCIENCE

YOJAR

GOLDEN POO

LVLUP NUTRITION